Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial

Samankaltaisia teoksia

• Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
  Tekijä: Jespersen, Christian M, et al.
  Julkaistu: (2006)
• Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease
  Tekijä: Gluud, Christian, et al.
  Julkaistu: (2008)
• Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
  Tekijä: Winkel, Per, et al.
  Julkaistu: (2017)
• Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
  Tekijä: Sieper, Joachim, et al.
  Julkaistu: (2014)
• Clarithromycin in stable coronary heart disease may increase mortality
  Julkaistu: (2006)